The primary objective of this sub-study, 2019-01B, is to collect blood specimens for research use in the development and validation of a blood-based test for colorectal cancer (CRC).
Subjects who consent to enroll in Exact Sciences Protocol 2019-01 BLUE-C, will be invited to participate in this sub-study. Subjects enrolled in the Exact Sciences Protocol 2019-01 BLUE-C, who provide written informed consent to participate in this sub-study, will have a blood sample collected at enrollment.
Study Type
OBSERVATIONAL
Enrollment
23,494
Subjects participating in the study will have blood drawn at enrollment.
Blood-based biomarkers associated with genetic and epigenetic alterations.
Time frame: Point in time blood collection (1 day) at enrollment
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Parkway Medical Center
Birmingham, Alabama, United States
Summit Internal Medicine, PC
Birmingham, Alabama, United States
University of Alabama at Birmingham
Birmingham, Alabama, United States
Cullman Clinical Trials
Cullman, Alabama, United States
Digestive Health Specialists of the Southeast
Dothan, Alabama, United States
G & L Research
Foley, Alabama, United States
Medical Affiliated Research Center
Huntsville, Alabama, United States
East View Medical Research, LLC
Mobile, Alabama, United States
GI Associates of West Alabama, P.C
Tuscaloosa, Alabama, United States
Mayo Clinic - AZ
Phoenix, Arizona, United States
...and 184 more locations